SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-028775
Filing Date
2022-08-09
Accepted
2022-08-09 16:31:39
Documents
90
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q celu-10q_20220630.htm   iXBRL 10-Q 3818637
2 EX-31.1 celu-ex311_6.htm EX-31.1 20873
3 EX-31.2 celu-ex312_9.htm EX-31.2 20869
4 EX-32.1 celu-ex321_7.htm EX-32.1 10863
5 EX-32.2 celu-ex322_8.htm EX-32.2 10813
  Complete submission text file 0001564590-22-028775.txt   15700006

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA celu-20220630.xsd EX-101.SCH 92666
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celu-20220630_cal.xml EX-101.CAL 59726
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celu-20220630_def.xml EX-101.DEF 321945
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE celu-20220630_lab.xml EX-101.LAB 604385
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celu-20220630_pre.xml EX-101.PRE 494048
84 EXTRACTED XBRL INSTANCE DOCUMENT celu-10q_20220630_htm.xml XML 3864098
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38914 | Film No.: 221148837
SIC: 2834 Pharmaceutical Preparations